Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Anti-Asthmatics And COPD Drugs Market Global Briefing 2017

Anti-Asthmatics And COPD Drugs Market Global Briefing 2017

From $1,000.00

Including: Long Acting Beta Agonists, Short Acting Beta Agonists, Anticholinergics, Inhaled Corticosteroids, Leukotriene Antagonists, And Combination Drugs.
Covering: Boehringer Ingelheim, Pfizer Inc., Merck & Co, GlaxoSmithKline


Clear selection
SKU: 2268. Category: .
Description

Anti-Asthmatics And COPD Drugs Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and copd drugs market.

Description

The Anti-Asthmatics And COPD Drugs Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The anti-asthmatics and copd drugs market is one of the segments in the respiratory diseases drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the anti-asthmatics and copd drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the anti-asthmatics and copd drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the anti-asthmatics and copd drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Long Acting Beta Agonists, Short Acting Beta Agonists, Anticholinergics, Inhaled Corticosteroids, Leukotriene Antagonists, And Combination Drugs.

Companies Mentioned: Boehringer Ingelheim, Pfizer Inc., Merck & Co, GlaxoSmithKline.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Cough and cold Preparations Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Anti-Asthmatics And COPD Drugs Market Characteristics
3. Anti-Asthmatics And COPD Drugs Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Anti-Asthmatics And COPD Drugs Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Anti-Asthmatics And COPD Drugs Market Geography Split
6. Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2016, By Region
7. Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2016, By Country
8. Anti-Asthmatics And COPD Drugs Market Segmentation
9. Anti-Asthmatics And COPD Drugs Competitive Landscape
Boehringer Ingelheim
Pfizer Inc.
Merck & Co.
GlaxoSmithKline
10. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
11. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Anti-Asthmatics And COPD Drugs Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Anti-Asthmatics And COPD Drugs Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Anti-Asthmatics And COPD Drugs Market, Split By Region, 2016, $ Billion
Table 4: Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2016, By Region
Table 5: Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2016, By Country
Table 6: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Anti-Asthmatics And COPD Drugs Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Anti-Asthmatics And COPD Drugs Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Anti-Asthmatics And COPD Drugs Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Anti-Asthmatics And COPD Drugs Market, Split By Region, 2016, $ Billion
Figure 4: Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2016, By Region
Figure 5: Anti-Asthmatics And COPD Drugs Market As A Proportion of Respiratory Diseases Drugs Market, 2020, By Country
Figure 6: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Anti-Asthmatics And COPD Drugs Market, Split By Segments, 2016, $ Billion
Executive Summary
The anti-asthmatics and COPD drugs market covers drugs that treat different types of asthma and COPD. These indications include Allergic rhinitis, Exercise-Induced Asthma, Cough-Variant Asthma, Occupational Asthma, Nocturnal Asthma, Chronic bronchitis, and Emphysema. Based on therapeutic type, the market is segmented into long acting beta agonists, short acting beta agonists, anticholinergics, inhaled corticosteroids, leukotriene antagonists, and combination drugs.

The global anti-asthmatics and copd drugs market was estimated to be around $34.4 billion as of 2016. The global anti-asthmatics and copd drugs made up around 34.4% of the overall respiratory diseases drugs market in 2016. The anti-asthmatics and copd drugs market was the largest market in the global respiratory diseases drugs market in 2016.

Collaborations
Top competitors in the anti-asthmatics and COPD market are strategically partnering and collaborating with other companies to broaden their product portfolio is a major trend in this market. For instance, in March 2017, AstraZeneca announced collaboration with Circassia Pharmaceuticals plc, (a UK based respiratory biopharmaceutical company) for the development and commercialisation of Tudorza and Duaklir in the US. Tudorza and Duaklir are used in the treatment of chronic obstructive pulmonary disease (COPD).

New Product Launches
Companies in this market are working towards constant innovation in design and technology to make anti-asthamatics drugs market. For instance, in May 2017, Teva Pharmaceutical Industries Limited launched Cinqaero in Russia. It is a new drug for the treatment of severe uncontrolled, eosinophilic asthma in adults. Through this product launch Teva Pharmaceutical Industries Limited focuses to strengthen its position in anti-asthmatics drugs market in Russia.
Get Customized Report
Please fill in your details. Our team will get back to you